Drugs & medicalClass II

Amerisource Health Services LLC recalls Prazosin Hydrochloride, Capsules, USP, 5 mg, 20 capsules (5x4) cartons, Rx only, Distributed by American Health Packaging,…

Failed Impurities/Degradation Specification: presence of N-nitroso Prazosin impurity C above the Carcinogenic Potency Categorization Approach (CPCA) acceptable intake limit

Read the official notice →
Date
2025-11-05
Country
United States
Brand
Amerisource Health Services
Product
Prazosin Hydrochloride, Capsules, USP, 5 mg, 20 capsules (5x4) cartons, Rx only, Distributed by American Health Packaging, Columbus, Ohio…
Classification
Class II
Units
Nationwide within the United States
Category
Drugs & medical
Source
FDA · Drug

Copied automatically from the US Food and Drug Administration. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer

What to do

  1. Check the product name, strength and lot number against the official notice.
  2. Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
  3. Ask the pharmacy or supplier about a replacement or refund.

General guidance from Recall Atlas. The official notice from the US Food and Drug Administration has the exact models, batch codes and remedy, and it takes priority.

More Amerisource Health Services recalls

  1. 2026-05-27
  2. US
    Drugs & medicalClass III

    Amerisource Health Services LLC recalls Primidone Tablets, USP, 50 mg, 100 Tablets (10 x 10 unit dose blister) per carton, Rx only, Distributed by: American Health…

    Cross contamination with other products: API contaminated with trace amounts of Acemetacin API.

    FDA · DrugAmerisource Health Services LLCUSA NationwideOfficial notice →
  3. 2026-04-01
  4. US
  5. 2026-02-18
  6. US
    Drugs & medicalClass II

    Amerisource Health Services LLC recalls Oxycodone Hydrochloride Tablets, USP (CII), 5 mg, 100-Count (10 x 10) blister cards per carton, Rx Only, The drug product…

    Defective container: card seal defects (weak/non-existent seals), leading to the tablets falling out of their cavities.

    FDA · DrugAmerisource Health Services LLCNationwide in the USAOfficial notice →
  7. 2025-10-22
  8. US
    Drugs & medicalClass II

    Amerisource Health Services LLC recalls Sucralfate Tablets, USP 1 gram, 100 Tablets, (10x10), Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217,…

    CGMP Deviations: The recalling firm filed for Chapter 11 on September 30, 2024. As a result, it cannot monitor the quality program and hence cannot assure that products meet the identity, strength, quality, and purity…

    FDA · DrugAmerisource Health Services LLCNationwide within the United StatesOfficial notice →
  9. 2025-10-08
  10. US
  11. 2025-09-24
  12. US
    Drugs & medicalClass II

    Amerisource Health Services LLC recalls chlorproMAZINE Hydrochloride Tablets, USP, 200 mg, 100 (10x10) blisterpack per carton, Rx Only, Distributed by: American Health…

    Presence of a foreign substance.A specific lot of auxiliary polyester coil, used in product packaging at the manufacturing site, was detected with presence of a micro-organism. No micro-organism was detected on any…

    FDA · DrugAmerisource Health Services LLCNationwide in the USAOfficial notice →
All 31 Amerisource Health Services recalls →

Other drugs & medical recalls in the United States

  1. 2025-11-05
  2. US
  3. US
    Drugs & medicalClass II

    Heritage Pharmaceuticals Inc recalls Desipramine Hydrochloride Tablets, USP, 25 mg, 100 count bottle (NDC 23155-579-01), Rx only, Manufactured by: USV Private Limited,…

    CGMP Deviations: N-Nitroso Desipramine impurity exceeding the permissible acceptable daily intake level.

    FDA · DrugHeritage Pharmaceuticals IncU.S. Nationwide.Official notice →
  4. US
    Drugs & medicalClass II

    Teva Pharmaceuticals USA, Inc recalls Prazosin Hydrochloride, Capsules, USP, 2 mg, Rx only, Distributed by TEVA PHARMACEUTICALS USA, INC., North Wales, PA 19454, a) 100…

    CGMP Deviations-Test results for N-nitroso Prazosin impurity C that are above the Carcinogenic Potency Categorization Approach (CPCA) acceptable intake limit for the above specified lots.

    FDA · DrugTeva Pharmaceuticals USA, IncU.S. NationwideOfficial notice →
  5. US
    Drugs & medicalClass II

    Breckenridge Pharmaceutical, Inc. recalls Duloxetine Delayed-Release Capsules, USP, 60 mg, a.) 90-count bottle (NDC: 51991-748-90), b.)1000-count bottle (NDC…

    CGMP Deviations: N-nitroso-duloxetine impurity above the safety assessment limit of 12.5ppm.

    FDA · DrugBreckenridge Pharmaceutical, Inc.U.S. NationwideOfficial notice →
  6. US
    Drugs & medicalClass II

    Samsung Bioepis Co., Ltd. recalls HADLIMA (adalimumab-bwwd) injection, 40mg/0.8 mL, 2 Single-dose Prefilled Syringes per carton, Rx only, Manufactured for: Organon LLC,…

    Lack of Assurance of Sterility.

    FDA · DrugSamsung Bioepis Co., Ltd.Distributed only to one warehouse in NJ. with no further distributionOfficial notice →
  7. 2025-10-29
  8. US
    Drugs & medicalClass II

    GE MEDICAL SYSTEMS ISRAEL, FUNCTIONAL IMAGING recalls Elscint SPX6; dual-head nuclear medicine gamma camera designed specifically for cardiac imaging

    GE HealthCare has become aware that certain Nuclear Medicine systems that are past the End of Guaranteed Service could have been transported or relocated without adequate detector support. This could result in…

    FDA · DeviceGE MEDICAL SYSTEMS ISRAEL, FUNCTIONAL IMAGINGWorldwideOfficial notice →
See all drugs & medical recalls →